A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their body ...

As AI agents grow more autonomous, developers are already giving them crypto wallets, allowing software to hold assets, pay for services, trade tokens and even hire other agents. The technical pieces ...